Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, ...

UBS is in talks to form an Indian wealth management joint venture with Mumbai-based 360 One WAM, two sources with direct ...

But in an accompanying survey, 500 owners of businesses with annual revenues above $1 million leaned toward Trump, favoring ...

Fintel reports that on September 26, 2024, UBS downgraded their outlook for GE HealthCare Technologies ( BVC:GEHC) from ...

Pay on Results PR is proud to announce its inclusion in the prestigious UK Fast Growth Index for 2024, supported by ...

Mumbai: UBS is in discussions to establish an Indian wealth management joint venture with Mumbai-based 360 One WAM, Reuters ...

UBS has maintained a sell rating on Hero MotoCorp with a target price of ₹3,350, citing concerns over declining retail market ...

An overwhelming majority of both investors and business owners cite the economy as the top election issue, meanwhile, ...

"These two markets account for 70-80 per cent of sector profits and would imply lower growth. The balance sheets are healthy ...

Fintel reports that on September 26, 2024, UBS downgraded their outlook for Smartsheet (NYSE:SMAR) from Buy to Neutral.

UBS analyst Charles Eden maintained a Buy rating on Symrise (0G6T – Research Report) today and set a price target of €139.00. The ...

The Reserve Bank of India's Monetary Policy Committee (MPC) is anticipated to begin easing interest rates in December 2024, ...